EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, DCTH: Delcath Systems Inc

04 Nov 25 15:59
LAST:

9.090

CHANGE:
 0.44		OPEN:
9.080		HIGH:
9.660		ASK:
0.115		VOLUME:
1.41M
CHG(%):
4.62		PREV:
9.520		LOW:
8.700		BID:
3.880		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 259.0809.6608.7009.0801.75M
03 Nov 259.8109.9009.2509.5201.3M
31 Oct 259.49010.0309.4109.8301.27M
30 Oct 259.7009.9809.1509.400989.9K
29 Oct 2510.07010.1309.7109.7201.01M
28 Oct 259.92010.1809.70010.1501.1M
27 Oct 2510.34010.3409.7509.9901.7M
24 Oct 2510.51010.62710.05010.2301.1M
23 Oct 2510.35010.80010.30510.3801.12M
22 Oct 2511.39011.39010.06010.3601.54M

COMPANY PROFILE

Name:Delcath Systems Inc
About:Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.
Sector:Healthcare
Address:566 Queensbury Avenue, New York, NY, United States, 12804
Website:https://www.delcath.com
CUSIP:24661P807
CIK:0000872912
ISIN:US24661P8077
FIGI:BBG000BY2VF5
LEI:549300NVPLITUM6URT02

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:123.33 
Forward P/E:-34.69 
Price to Sales:5.53 
Price to Book:3.70 
EPS Ratio:0.09 
Revenue:70.24M 
EBITDA:5.18M 
Shares:34.98M 
Market Cap:317.98M 

TECHNICAL INDICATORS

MA5:9.514.6%
MA10:9.878.5%
MA20:10.6116.8%
MA50:10.8819.7%
MA100:11.3624.9%
MA200:12.7940.7%
RSI14:29.78 
WPR14:-100.00 
MTM14:-3.28
ROC14:-0.27 
ATR:0.80 
Week High:10.1812.0%
Week Low:8.704.5%
Month High:12.7039.7%
Month Low:8.7040.7%
Year High:18.23100.6%
Year Low:8.704.5%
Volatility:15.30 

RECENT SPLITS

Date Ratio
24 Dec 20191-700
22 Oct 20191-100
03 May 20181-500
02 May 20181-500
06 Nov 20171-350
21 Jul 20161-16
09 Apr 20141-16